MARKET

XENE

XENE

Xenon Pharmaceut
NASDAQ
60.36
+0.23
+0.38%
After Hours: 60.36 0 0.00% 16:11 06/30 EDT
OPEN
60.09
PREV CLOSE
60.13
HIGH
60.53
LOW
59.56
VOLUME
1.25M
TURNOVER
--
52 WEEK HIGH
63.95
52 WEEK LOW
30.00
MARKET CAP
5.83B
P/E (TTM)
-12.8295
1D
5D
1M
3M
1Y
5Y
1D
Analyst Warns Biohaven's Lead Drug May Struggle To Stand Out
Benzinga · 1d ago
Biohaven downgraded to Underperform from Neutral at BofA
TipRanks · 1d ago
Weekly Report: what happened at XENE last week (0622-0626)?
Weekly Report · 1d ago
Leerink Partners Sticks to Its Buy Rating for Xenon (XENE)
TipRanks · 6d ago
Weekly Report: what happened at XENE last week (0615-0619)?
Weekly Report · 06/22 09:26
Weekly Report: what happened at XENE last week (0608-0612)?
Weekly Report · 06/15 09:26
Weekly Report: what happened at XENE last week (0601-0605)?
Weekly Report · 06/08 09:25
Xenon Shareholders Approve Directors, Pay and Incentive Plan
TipRanks · 06/03 21:13
More
About XENE
Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the advanced, clinically validated potassium channel modulator in late-stage clinical development for the treatment of multiple indications that include epilepsy, including focal onset seizures (FOS), and primary generalized tonic-clonic seizures (PGTCS), as well as neuropsychiatric disorders including major depressive disorder (MDD), and bipolar depression (BPD). The Company is evaluating multiple therapeutic candidates targeting Kv7, Nav1.7, and Nav1.1 across various indications.

Webull offers Xenon Pharmaceuticals Inc stock information, including NASDAQ: XENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XENE stock methods without spending real money on the virtual paper trading platform.